What You Should Know:
- Glytec recently announced that it has been selected by CPS Solutions, LLC (CPS), a leading provider of enterprise pharmacy solutions to hospitals and health systems, to serve as an insulin management technology resource for CPS’ more than 2,200 pharmacy professionals across 800-plus healthcare facilities nationwide.
- Through this collaboration, CPS client facilities may contract for Glytec’s eGlycemic Management System® (eGMS) and Glytec’s technical resources to be
Read More
FDA| Healthcare FDA Regulation | Policy, News, Analysis, Insights - HIT Consultant
Health-Tech C2Q:22 Preview: 5 Key Driving Factors to Watch
What You Should Know:
- David Larsen, healthcare IT and digital health analyst at BTIG published a note highlighting his preview for health-tech Q2 earnings.
- Given high inflation rates, costs for traveling nurses, and light volumes in 2Q:22, he is cautious on stocks that sell into the acute care market in the near term.
An Overview
According to the report, there are many macro headwinds that continue to affect the HCIT sector and the broader market, including inflationary pricing
Read More
POGO Blood Glucose Monitoring Now Available in Kroger Health Pharmacies Nationwide
What You Should Know:
- Intuity Medical, Inc., a commercial-stage medical technology and digital health company focused on making life with diabetes easier, today announced that the POGO Automatic® Blood Glucose Monitoring System is now available at the more than 2,200 U.S. pharmacies of Kroger Health, the healthcare division of The Kroger Co.
- With POGO Automatic Monitors and Cartridges now available at all Kroger Health pharmacy locations, the simplicity of One-Step testing
Read More
GE Healthcare Makes Strategic Investment in AliveCor
What You Should Know:
- AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, recently announced its Series F Financing led by GE Healthcare.
- The round also included participation from Pegasus Tech Ventures) and existing investors including Khosla Ventures, Bold Capital Partners, Qualcomm Ventures, and WP Global Partners.
Providing End-to-End Cardiological Care Using Subscription Services
AliveCor, Inc. is transforming cardiological care using deep
Read More
Avenda Health Receives FDA Exemption for AI-Enabled Prostate Cancer Therapy
What You Should Know:
- Avenda Health, an AI healthcare company creating the future of prostate cancer care, has received FDA Investigational Device Exemption (IDE) for its FocalPoint ablation system. The IDE will allow the technology, powered by iQuest, to be used in a randomized control trial to show superiority over the standard of care for the treatment of prostate cancer.
- FocalPoint is Avenda Health’s focal laser ablation system designed to treat localized prostate cancer
Read More
Sibel Health Raises $33M for Advanced Wearable Sensors for RPM
What You Should Know:
- Sibel Health has recently closed a $33M Series B financing round, bringing Sibel's total funding to date to more than $50M.
- In addition, Sibel has announced two new executive appointments. Jon Otterstatter, the former CEO and co-founder of Preventice (acquired by Boston Scientific in 2021), will join as chairman of the board. Matthew Banet, Ph.D., a world expert in advanced body-worn sensors and previously the CTO and co-founder of toSense and Sotera, joins as
Read More
Mira Launches Ovum Wand to Predict Menopause and Monitor Fertility Status
What You Should Know:
- The FDA has listed Mira's new Mira Ovum Wand as an over-the-counter tool to detect the follicle-stimulating hormone (FSH) in urine. Starting October 2022, the product will be available to U.S. customers. The wands help monitor FSH levels to predict approaching menopause. They can also be used to monitor fertility and find possible causes of reproductive issues for women after 35.
- Mira's new Ovum Wand provides lab-accurate detection of the follicle-stimulating
Read More
Exo Acquires Medo to Make Ultrasounds Simple and Accessible
What You Should Know:
- Exo, a health information and devices company, today has announced it has acquired Medo, an FDA-cleared AI platform that makes ultrasound workflow faster, more reliable, and accessible to all.
- By integrating Medo’s AI, Exo enables more caregivers in more settings to capture and interpret medical images – allowing faster and more accurate diagnoses and treatment.
Make Medical Imaging as Easy as Snapping a Smartphone Photo
Ultrasound imaging is
Read More
Media Mix Transformation for Pharma Marketers: The Power of CTV & Digital Video
Consumers continue to cut ties with traditional TV and cable services, prompting industries like the prescription pharmaceutical industry to evolve their marketing mix to accommodate emerging media.
Pharma advertisers spend billions on traditional TV advertising, but as streaming services began to experience explosive growth early in the pandemic, advertising strategies had to adapt. TV-centric advertisers relied on (and still rely on) dayparting (scheduling ads during certain times of the
Read More
FDA Awards 510(k) Clearances for ZEUS System/Zio Watch
What You Should Know:
- Today, iRhythm (a digital health company) and Verily (Alphabet’s life sciences research organization) announced joint FDA 510(k) clearances for the ZEUS System and Zio Watch. Together they create an integrated, prescription-based solution that will improve clinician workflows, care pathways and the patient experience.
- The ZEUS System is the AI algorithm and solution component of the Zio Watch – a clinical grade, long-term and noninvasive wearable that not only
Read More
